Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Tangible Net Worth Ratio
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A tangible net worth ratio. Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) has a Tangible Net Worth Ratio of 84.7% as of September 2025. This metric is calculated by deducting intangible assets (CN¥6.78 Billion) from net assets (CN¥44.24 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Shenzhen Mindray Bio-Medical Electronics (300760) strategic investment index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (2014–2024)
Tangible net worth ratio of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2014 to 2024. This chart shows how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's Tangible Net Worth Ratio has changed across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 84.7%, reflecting net assets of CN¥44.24 Billion with intangible assets of CN¥6.78 Billion CNY. See working capital to net assets of Shenzhen Mindray Bio-Medical Electronics to evaluate short-term liquidity relative to the company's equity base.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Tangible Net Worth Ratio by Year (2014–2024)
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A tangible net worth ratio by year from 2014 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2014 to 2024, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Shenzhen Mindray Bio-Medical Electronics market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 82.6% | CN¥40.76 Billion | CN¥7.08 Billion | CN¥56.64 Billion | ▼ -9.7 pp |
| 2023 | 92.3% | CN¥33.35 Billion | CN¥2.57 Billion | CN¥47.94 Billion | ▼ -0.6 pp |
| 2022 | 92.9% | CN¥32.00 Billion | CN¥2.27 Billion | CN¥46.75 Billion | ▲ +1.1 pp |
| 2021 | 91.8% | CN¥26.97 Billion | CN¥2.20 Billion | CN¥38.10 Billion | ▼ -2.5 pp |
| 2020 | 94.3% | CN¥23.29 Billion | CN¥1.32 Billion | CN¥33.31 Billion | ▲ +0.2 pp |
| 2019 | 94.1% | CN¥18.62 Billion | CN¥1.10 Billion | CN¥25.63 Billion | ▲ +0.9 pp |
| 2018 | 93.2% | CN¥15.18 Billion | CN¥1.04 Billion | CN¥21.63 Billion | ▲ +7.6 pp |
| 2017 | 85.6% | CN¥6.65 Billion | CN¥958.16 Million | CN¥14.44 Billion | ▲ +5.9 pp |
| 2016 | 79.7% | CN¥4.60 Billion | CN¥935.69 Million | CN¥12.97 Billion | ▼ -6.7 pp |
| 2015 | 86.4% | CN¥6.54 Billion | CN¥890.36 Million | CN¥12.36 Billion | ▼ -1.4 pp |
| 2014 | 87.8% | CN¥9.66 Billion | CN¥1.18 Billion | CN¥14.58 Billion | — |